Literature DB >> 8072642

Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study.

T Billette de Villemeur1, A Gelot, J P Deslys, D Dormont, C Duyckaerts, L Jardin, J Denni, O Robain.   

Abstract

Since 1985, several cases of Creutzfeldt-Jakob disease, occurring after a treatment by human cadaveric hormone have been reported. Three new iatrogenic cases observed in French patients (two children and one young adult) are described here. Neuropathological study displayed the classical aspects of previously reported sporadic cases of Creutzfeldt-Jakob disease in adults, including severe cortical spongiform change with numerous vacuoles within neuronal dendrites, diffuse astrogliosis and neuronal loss. In addition, the iatrogenic cases described here included two more unusual points: (i) they were homozygotic for the PrP gene on codon 129 and therefore a genetic predisposition could be suspected; (ii) numerous kuru plaques were scattered in the cerebral cortex, the subcortical white matter and in the cerebellar cortex. They were decorated with a PrP monoclonal antibody, but not with a beta A4 antibody. This last point underlines the similarities between iatrogenic Creutzfeldt-Jakob disease and kuru.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8072642     DOI: 10.1111/j.1365-2990.1994.tb01169.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  8 in total

1.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

2.  Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases.

Authors:  Damien Galanaud; S Haik; M G Linguraru; J-P Ranjeva; B Faucheux; E Kaphan; N Ayache; J Chiras; P Cozzone; D Dormont; J-P Brandel
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-29       Impact factor: 3.825

3.  Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?

Authors:  Atsushi Kobayashi; Piero Parchi; Masahito Yamada; Paul Brown; Daniela Saverioni; Yuichi Matsuura; Atsuko Takeuchi; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

Review 4.  Prion protein scrapie and the normal cellular prion protein.

Authors:  Caroline J Atkinson; Kai Zhang; Alan L Munn; Adrian Wiegmans; Ming Q Wei
Journal:  Prion       Date:  2016       Impact factor: 3.931

5.  Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.

Authors:  Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; Katie Fox; Sharon Cooper; Sabrina Cronier; Emmanuel A Asante; Simon Mead; Sebastian Brandner; Andrew F Hill; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-03       Impact factor: 11.205

6.  Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.

Authors:  Ignazio Cali; Cathleen J Miller; Joseph E Parisi; Michael D Geschwind; Pierluigi Gambetti; Lawrence B Schonberger
Journal:  Acta Neuropathol Commun       Date:  2015-06-25       Impact factor: 7.801

Review 7.  Review. The origin of the prion agent of kuru: molecular and biological strain typing.

Authors:  Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Emmanuel A Asante; Sebastian Brandner; John Collinge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-11-27       Impact factor: 6.237

8.  Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease.

Authors:  Sebastian Brandner; Jerome Whitfield; Ken Boone; Anderson Puwa; Catherine O'Malley; Jacqueline M Linehan; Susan Joiner; Francesco Scaravilli; Ian Calder; Michael P Alpers; Jonathan D F Wadsworth; John Collinge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-11-27       Impact factor: 6.237

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.